SCHEMBL23094273

SCHEMBL23094273

N/C(Cc1ccc(Cl)cc1)=N\OC(=O)COc1ccc(Cl)cc1Cl

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 9/20 0.69
▸ L3MBTL1 Q9Y468 4/20 0.64
▸ MAPT P10636 4/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ NPSR1 Q6W5P4 1/20 0.63
▸ NPC1 O15118 3/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ LMNA P02545 2/20 0.61
▸ POLB P06746 1/20 0.59
▸ GAA P10253 1/20 0.58
▸ NFKB1 P19838 1/20 0.58
▸ NFKB2 Q00653 1/20 0.58
▸ RELA Q04206 1/20 0.58
▸ HPGD P15428 1/20 0.56
▸ TP53 P04637 1/20 0.55
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27374179 0.93 TDP1 (0.69) TDP1L3MBTL1MAPTSMN1; SMN2NPSR1
SCHEMBL23094207 0.88 TDP1 (0.78) TDP1L3MBTL1MAPTSMN1; SMN2NPSR1
SCHEMBL9809465 0.86 TDP1 (0.66) TDP1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL27374100 0.82 NPC1 (0.66) TDP1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL23094277 0.82 TDP1 (1.00) TDP1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL30750934 0.81 MAPT (0.84) TDP1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL27374467 0.81 MAPT (0.84) TDP1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL23094156 0.81 TDP1 (1.00) TDP1L3MBTL1MAPTSMN1; SMN2NPSR1
SCHEMBL23094218 0.80 TDP1 (0.58) TDP1L3MBTL1MAPTSMN1; SMN2NPSR1
SCHEMBL31503214 0.78 NPC1 (0.61) TDP1L3MBTL1MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 TDP1 4664/4885L3MBTL1 2077/4885MAPT 4344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback